African vaccine manufacturing

CHAI’s work in the African Vaccine Manufacturing (AVM) space has been targeted at achieving a fit-for-purpose, sustainable vaccine manufacturing footprint. These publications represent some of the work CHAI has undertaken at the ecosystem level, informed by work with individual manufacturers and governments, to ensure that the vaccine landscape becomes more pandemic prepared, achieves greater security of vaccine supply, and promotes economic viability for vaccine manufacturing projects.